Bortezomib, Thalidomide, and Dexamethasone (Vtd) Versus Vtd Plus Cyclophosphamide as Induction Therapy in Previously Untreated Multiple Myeloma Patients Eligible for Hdt-Asct: A Randomized Phase 2 Trial.
AuthID
P-003-EAH
P-003-EAH